We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
201
GSA Capital Partners
United Kingdom
$1.9M +$1.75M +23,698 New
LPL Financial
202
LPL Financial
California
$1.87M +$1.72M +23,344 New
NIP
203
Nicholas Investment Partners
California
$1.87M +$1.72M +23,323 New
HIMCH
204
Hartford Investment Management Co (HIMCO)
Connecticut
$1.78M +$1.65M +22,345 New
MSU
205
Mizuho Securities USA
New York
$1.78M +$1.65M +22,339 New
OI
206
Oakbrook Investments
Illinois
$1.76M +$1.62M +21,953 New
CCMH
207
Cornerstone Capital Management Holdings
New York
$1.71M +$1.57M +21,314 New
CI
208
Cowen Inc
New York
$1.6M +$1.47M +20,000 New
TP
209
Traxis Partners
Connecticut
$1.6M +$1.47M +20,000 New
FCBT
210
First Citizens Bank & Trust
North Carolina
$1.56M +$1.43M +19,470 New
PI
211
Placemark Investments
Illinois
$1.55M +$1.42M +19,286 New
NI
212
Numeric Investors
Massachusetts
$1.52M +$1.4M +19,000 New
PA
213
Pinnacle Associates
New York
$1.46M +$1.34M +18,250 New
PNC Financial Services Group
214
PNC Financial Services Group
Pennsylvania
$1.45M +$1.34M +18,142 New
PP
215
PDT Partners
New York
$1.44M +$1.33M +18,005 New
TMAM
216
Tokio Marine Asset Management
Japan
$1.43M +$1.31M +17,851 New
BPBT
217
Boston Private Bank & Trust
Massachusetts
$1.39M +$1.28M +17,414 New
ACI
218
Advance Capital I
Michigan
$1.39M +$1.27M +17,300 New
IIM
219
Ipswich Investment Management
Massachusetts
$1.32M +$1.21M +16,465 New
Cambridge Investment Research Advisors
220
Cambridge Investment Research Advisors
Iowa
$1.31M +$1.2M +16,307 New
AG
221
Aperio Group
California
$1.28M +$1.18M +15,990 New
Mackenzie Financial
222
Mackenzie Financial
Ontario, Canada
$1.23M +$1.13M +15,300 New
SM
223
Sabby Management
Florida
$1.21M +$1.11M +15,108 New
PCM
224
Palisade Capital Management
New Jersey
$1.2M +$1.1M +14,999 New
AT
225
Arden Trust
Delaware
$1.2M +$1.1M +14,948 New
7 8
9
10 11

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.